Article
Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.
Atherosclerosis - 1 Jul 2012
Gungor Zeynep, Anuurad Erdembileg, Enkhmaa Byambaa, Zhang Wei, Kim Kyoungmi, Berglund Lars
Abstract excerpt
OBJECTIVE: Apolipoprotein E (apoE) has been implicated as conveying increased risk for coronary artery disease (CAD). Previous studies suggest a role of apoE as a modulator of immune response and inflammatory properties. We hypothesized that the presence of apo E4 is associated with an increased inflammatory burden in subjects with CAD as compared to subjects without CAD. METHODS: ApoE genotypes, systemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
